Focusing on Quality of Life, Improving Outcomes in Ovarian Cancer

As treatments continue to improve — thus increasing the lifespan of patients with ovarian cancer – it is important that patients and providers pay attention to any lasting side effects, explained Maurie Markman, M.D., president of medicine and science at the Cancer Treatment Centers of America.

Patients are now living a number of years longer after being treated for ovarian cancer, and outcomes will continue to improve as more drug choices become available and providers have a better understanding of how to sequence them, and which patients should receive which agents.